A
Andrew P Read
Researcher at St Mary's Hospital
Publications - 90
Citations - 5385
Andrew P Read is an academic researcher from St Mary's Hospital. The author has contributed to research in topics: Gene & Locus (genetics). The author has an hindex of 33, co-authored 85 publications receiving 5281 citations.
Papers
More filters
Journal ArticleDOI
SOX10 mutations in patients with Waardenburg-Hirschsprung disease.
Veronique Pingault,Nadege Bondurand,Kirsten Kuhlbrodt,Derk E. Goerich,Marie Odette Préhu,Aldamaria Puliti,Beate Herbarth,Irm Hermans-Borgmeyer,Eric Legius,Gert Matthijs,Jeanne Amiel,Stanislas Lyonnet,Isabella Ceccherini,Giovanni Romeo,Jill Clayton Smith,Andrew P Read,Michael Wegner,Michel Goossens +17 more
TL;DR: It is shown that patients from four families with WS4 have mutations in SOx10, whereas no mutation could be detected in patients with HSCR alone, and this point to an essential role ofSOx10 in the development of two neural crest-derived human cell lineages.
Journal ArticleDOI
Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene
Mayada Tassabehji,Andrew P Read,Valerie Newton,Rodney Harris,Rudi Balling,Peter Gruss,Tom Strachan +6 more
TL;DR: It is shown that some families with WS have mutations in the human homologue9 of Pax-3, which is one of a family of eight Pax genes known in mice which are involved in regulating embryonic development and which contains a highly conserved transcription control sequence, the paired box.
Journal ArticleDOI
Further experience of vitamin supplementation for prevention of neural tube defect recurrences.
R.W. Smithells,Mary J. Seller,Rodney Harris,D.W. Fielding,C J Schorah,N.C. Nevin,Sheila Sheppard,Andrew P Read,S. Walker,J. Wild +9 more
TL;DR: In accordance with a previous protocol, a second cohort of 254 mothers with a history of previous neural tube defect births was before a subsequent conception and continued until the time of the second missed menstrual period, finding no recurrences among the offspring of a further 114 mothers whose duration of supplementation fell short of the full regimen.
Journal ArticleDOI
Assessing Genetic Risks: Implications for Health and Social Policy
TL;DR: In the future of all-conquering genetic technology, who should be screened for what and by whom?
Journal ArticleDOI
Structure and expression of the Huntington's disease gene: Evidence against simple inactivation due to an expanded CAG repeat
Christine Ambrose,Mabel P. Duyao,Glenn Barnes,Gillian P. Bates,Carol Lin,Jayalakshmi Srinidhi,Sarah Baxendale,Holger Hummerich,Hans Lehrach,Michael R. Altherr,John J. Wasmuth,Alan Buckler,Deanna Church,David E. Housman,Mary Berks,Gos Micklem,Richard Durbin,Alan Dodge,Andrew P Read,James F. Gusella,Marcy E. MacDonald +20 more
TL;DR: Observations suggest that the dominant HD mutation either confers a new property on the mRNA or alters an interaction at the protein level, suggesting the operation of interacting factors in determining specificity of cell loss.